---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-021303"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T03:58:00.075716+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences Q1 revenue $1.5M (down 53% YoY) but gross profit improves $922k

## Summary
- Total revenues $1.5M vs $3.2M; prior year included $1.8M in discontinued products.
- Loss from operations improved to $4.0M from $4.6M; operating expenses fell 29% to $5.6M.
- Cost of revenues down to $825k from $3.5M, driving $922k gross profit improvement.
- Private placement financing impact on net loss still under review; Q1 10-Q to be filed next week.
- GoodWheat pasta named 'Best New Product' by Retail Dietitians Business Alliance.

## SEC filing metadata
- accession: 0000950170-23-021303
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/0000950170-23-021303-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/rkda-20230511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-021303
- JSON: https://secwatch.observer/filing/0000950170-23-021303.json
- Plain text: https://secwatch.observer/filing/0000950170-23-021303.txt

## Key facts
- Earnings Releases
  Arcadia Biosciences, Inc. reported financial results for first quarter ended March 31, 2023.
  - Period: first quarter ended March 31, 2023
  - Result: reported results
  source text: On May 11, 2023 Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/0000950170-23-021303-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
